Multiple Myeloma
Latest News
FDA approves new CAR T-cell treatment for multiple myeloma
Study results show that this treatment for refractory/relapsed multiple myeloma can provide deep, durable responses and long treatment-free...
News
100 coauthored papers, 10 years: Cancer transplant pioneers model 'team science'
MSKCC medical oncologists share expertise in HSCT, Spanish background, a gift for mentoring, and 100 peer-reviewed publications written together...
Conference Coverage
Isatuximab added to RVd boosts response in new myeloma
A drug approved in 2020 for treatment of advanced multiple myeloma has been shown to benefit patients newly diagnosed with the disease.
News
FDA approves time-saving combo for r/r multiple myeloma
“The approval will help clinicians address unmet patient needs by reducing the administration time from hours to just minutes and reducing the...
News
Severe COVID two times higher for cancer patients
News
FDA warns of higher death risk with Pepaxto in multiple myeloma
The FDA also hinted at “a future public meeting to discuss the safety findings and explore the continued marketing of Pepaxto,” which has a price...
Conference Coverage
Personalized cancer vaccine shows early promise across tumor types
The vaccine consists of patient-specific synthetic neoantigen peptides and is given to patients in the adjuvant setting.
Article
Cancer screening stopped by pandemic: Repercussions to come?
News
Steroids can be stopped in some older multiple myeloma patients
News
First CAR T-cell therapy for multiple myeloma: Abecma
“The results of this trial represent a true turning point in the treatment of this disease.”